BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scoville EA, Allaman MM, Brown CT, Motley AK, Horst SN, Williams CS, Koyama T, Zhao Z, Adams DW, Beaulieu DB, Schwartz DA, Wilson KT, Coburn LA. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn’s disease from ulcerative colitis and control subjects by serum metabolomic profiling. Metabolomics 2018;14. [DOI: 10.1007/s11306-017-1311-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 59] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Mao Q, Pan H, Zhang Y, Zhang Y, Zhu Q, Hong Y, Huang Z, Li Y, Feng X, Fang Y, Chen W, Chen P, Shen B, Ouyang H, Liang Y. GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis in the treatment of inflammatory bowel disease. Bioactive Materials 2023;19:251-67. [DOI: 10.1016/j.bioactmat.2022.04.001] [Reference Citation Analysis]
2 Singh A, Midha V, Mahajan R, Verma S, Kakkar C, Grover J, Singh D, Kaur R, Masih A, Bansal N, Wall C, Sood A. Evaluation of Nutritional Characteristics Reveals Similar Prevalence of Malnutrition in Patients with Ulcerative Colitis and Crohn's Disease. Dig Dis Sci 2022. [PMID: 36064826 DOI: 10.1007/s10620-022-07652-z] [Reference Citation Analysis]
3 González-dávila P, Schwalbe M, Danewalia A, Wardenaar R, Dalile B, Verbeke K, Mahata SK, El Aidy S. Gut microbiota transplantation drives the adoptive transfer of colonic genotype-phenotype characteristics between mice lacking catestatin and their wild type counterparts. Gut Microbes 2022;14:2081476. [DOI: 10.1080/19490976.2022.2081476] [Reference Citation Analysis]
4 Cortes GM, Marcialis MA, Bardanzellu F, Corrias A, Fanos V, Mussap M. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin. Front Microbiol 2022;13:856165. [PMID: 35391730 DOI: 10.3389/fmicb.2022.856165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Li M, Yang L, Mu C, Sun Y, Gu Y, Chen D, Liu T, Cao H. Gut Microbial Metabolome in Inflammatory Bowel Disease: from Association to Therapeutic Perspectives. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.03.038] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zheng L, Wen X, Duan S. Role of metabolites derived from gut microbiota in inflammatory bowel disease. WJCC 2022;10:2660-77. [DOI: 10.12998/wjcc.v10.i9.2660] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zheng L, Wen XL, Duan SL. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World J Clin Cases 2022; 10(9): 2658-2675 [DOI: 10.12998/wjcc.v10.i9.2658] [Reference Citation Analysis]
8 Katkar GD, Sayed IM, Anandachar MS, Castillo V, Vidales E, Toobian D, Usmani F, Sawires JR, Leriche G, Yang J, Sandborn WJ, Das S, Sahoo D, Ghosh P. Artificial intelligence-rationalized balanced PPARα/γ dual agonism resets dysregulated macrophage processes in inflammatory bowel disease. Commun Biol 2022;5:231. [PMID: 35288651 DOI: 10.1038/s42003-022-03168-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 El-Hindi K, Brachtendorf S, Hartel JC, Oertel S, Birod K, Merz N, Trautmann S, Thomas D, Weigert A, Schäufele TJ, Scholich K, Schiffmann S, Ulshöfer T, Utermöhlen O, Grösch S. T-Cell-Specific CerS4 Depletion Prolonged Inflammation and Enhanced Tumor Burden in the AOM/DSS-Induced CAC Model. Int J Mol Sci 2022;23:1866. [PMID: 35163788 DOI: 10.3390/ijms23031866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sirven MA, Venancio VP, Shankar S, Klemashevich C, Castellón-Chicas MJ, Fang C, Mertens-Talcott SU, Talcott ST. Ulcerative colitis results in differential metabolism of cranberry polyphenols by the colon microbiome in vitro. Food Funct 2021;12:12751-64. [PMID: 34847216 DOI: 10.1039/d1fo03047g] [Reference Citation Analysis]
11 Iyer N, Corr SC. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease. Nutrients 2021;13:4259. [PMID: 34959809 DOI: 10.3390/nu13124259] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 Aldars-García L, Gisbert JP, Chaparro M. Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review. Pharmaceuticals (Basel) 2021;14:1190. [PMID: 34832973 DOI: 10.3390/ph14111190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Jagt JZ, Struys EA, Ayada I, Bakkali A, Jansen EEW, Claesen J, van Limbergen JE, Benninga MA, de Boer NKH, de Meij TGJ. Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study. Inflamm Bowel Dis 2021:izab256. [PMID: 34757415 DOI: 10.1093/ibd/izab256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lee EG, Yoon YC, Yoon J, Lee SJ, Oh YK, Kwon SW. Systematic Review of Recent Lipidomics Approaches Toward Inflammatory Bowel Disease. Biomol Ther (Seoul) 2021;29:582-95. [PMID: 34565718 DOI: 10.4062/biomolther.2021.125] [Reference Citation Analysis]
15 Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:11682. [PMID: 34769112 DOI: 10.3390/ijms222111682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Deshpande D, Fuchs L, Klose CSN. Neuro-immune-metabolism: The tripod system of homeostasis. Immunol Lett 2021;240:77-97. [PMID: 34655659 DOI: 10.1016/j.imlet.2021.10.001] [Reference Citation Analysis]
17 Ding NS, McDonald JAK, Perdones-Montero A, Rees DN, Adegbola SO, Misra R, Hendy P, Penez L, Marchesi JR, Holmes E, Sarafian MH, Hart AL. Metabonomics and the Gut Microbiome Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease. J Crohns Colitis 2020;14:1090-102. [PMID: 32119090 DOI: 10.1093/ecco-jcc/jjaa039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
18 Martias C, Baroukh N, Mavel S, Blasco H, Lefèvre A, Roch L, Montigny F, Gatien J, Schibler L, Dufour-Rainfray D, Nadal-Desbarats L, Emond P. Optimization of Sample Preparation for Metabolomics Exploration of Urine, Feces, Blood and Saliva in Humans Using Combined NMR and UHPLC-HRMS Platforms. Molecules 2021;26:4111. [PMID: 34299389 DOI: 10.3390/molecules26144111] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
19 Notararigo S, Martín-Pastor M, Viñuela-Roldán JE, Quiroga A, Dominguez-Munoz JE, Barreiro-de Acosta M. Targeted 1H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF. J Mol Med (Berl) 2021;99:1251-64. [PMID: 34021361 DOI: 10.1007/s00109-021-02094-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Matthews C, Cotter PD, O' Mahony J. MAP, Johne's disease and the microbiome; current knowledge and future considerations. Anim Microbiome 2021;3:34. [PMID: 33962690 DOI: 10.1186/s42523-021-00089-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Khan F, Radovanovic A, Gojobori T, Kaur M. IBDDB: a manually curated and text-mining-enhanced database of genes involved in inflammatory bowel disease. Database (Oxford) 2021;2021:baab022. [PMID: 33929018 DOI: 10.1093/database/baab022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Shi Y, He W, Zhong M, Yu M. MIN score predicts primary response to infliximab/adalimumab and vedolizumab therapy in patients with inflammatory bowel diseases. Genomics 2021;113:1988-98. [PMID: 33872704 DOI: 10.1016/j.ygeno.2021.04.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Yamamoto M, Shanmuganathan M, Hart L, Pai N, Britz-McKibbin P. Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease. Metabolites 2021;11:245. [PMID: 33921143 DOI: 10.3390/metabo11040245] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
24 Zaiatz Bittencourt V, Jones F, Doherty G, Ryan EJ. Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab024. [PMID: 33693743 DOI: 10.1093/ibd/izab024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 2021;47:254-73. [PMID: 33576711 DOI: 10.1080/1040841X.2021.1876631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
26 Bauset C, Gisbert-Ferrándiz L, Cosín-Roger J. Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease. J Clin Med 2021;10:622. [PMID: 33562024 DOI: 10.3390/jcm10040622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
27 Ashokan M, Ramesha KP, Hallur S, Karthikkeyan G, Rana E, Azharuddin N, Raj SR, Jeyakumar S, Kumaresan A, Kataktalware MA, Das DN, Keshava Prasad TS. Differences in milk metabolites in Malnad Gidda (Bos indicus) cows reared under pasture-based feeding system. Sci Rep 2021;11:2831. [PMID: 33531582 DOI: 10.1038/s41598-021-82412-z] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
28 Han Z, Wang H, Guo D, Zhang J. Integrative transcriptomic and metabonomic profiling analyses reveal the molecular mechanism of Chinese traditional medicine huankuile suspension on TNBS-induced ulcerative colitis. Aging (Albany NY) 2021;13:5087-103. [PMID: 33535180 DOI: 10.18632/aging.202427] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Santoru ML, Piras C, Murgia F, Leoni VP, Spada M, Murgia A, Liggi S, Lai MA, Usai P, Caboni P, Manzin A, Atzori L. Metabolic Alteration in Plasma and Biopsies From Patients With IBD. Inflamm Bowel Dis 2021;27:1335-45. [PMID: 33512485 DOI: 10.1093/ibd/izab012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Liu F, Yao Y, Lu Z, Zhang Q, Liu C, Zhu C, Lin C. 5-Hydroxy-4-methoxycanthin-6-one alleviates dextran sodium sulfate-induced colitis in rats via regulation of metabolic profiling and suppression of NF-κB/p65 signaling pathway. Phytomedicine 2021;82:153438. [PMID: 33422953 DOI: 10.1016/j.phymed.2020.153438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
31 Jing W, Dong S, Luo X, Liu J, Wei B, Du W, Yang L, Luo H, Wang Y, Wang S, Lu H. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. Pharmacol Res 2021;164:105358. [PMID: 33285228 DOI: 10.1016/j.phrs.2020.105358] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
32 Sankarasubramanian J, Ahmad R, Avuthu N, Singh AB, Guda C. Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease. Front Med (Lausanne) 2020;7:606298. [PMID: 33330572 DOI: 10.3389/fmed.2020.606298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
33 Kent-Dennis C, Penner GB. Effects of lipopolysaccharide exposure on the inflammatory response, butyrate flux, and metabolic function of the ruminal epithelium using an ex vivo model. J Dairy Sci 2021;104:2334-45. [PMID: 33246619 DOI: 10.3168/jds.2020-19002] [Reference Citation Analysis]
34 Marques JG, Shokry E, Frivolt K, Werkstetter KJ, Brückner A, Schwerd T, Koletzko S, Koletzko B. Metabolomic Signatures in Pediatric Crohn's Disease Patients with Mild or Quiescent Disease Treated with Partial Enteral Nutrition: A Feasibility Study. SLAS Technol 2021;26:165-77. [PMID: 33207993 DOI: 10.1177/2472630320969147] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
35 Gallagher K, Catesson A, Griffin JL, Holmes E, Williams HRT. Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review. J Crohns Colitis 2021;15:813-26. [PMID: 33175138 DOI: 10.1093/ecco-jcc/jjaa227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
36 Longo S, Chieppa M, Cossa LG, Spinelli CC, Greco M, Maffia M, Giudetti AM. New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies. Proteomes 2020;8:18. [PMID: 32784952 DOI: 10.3390/proteomes8030018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Wasinger VC, Lu K, Yau YY, Nash J, Lee J, Chang J, Paramsothy S, Kaakoush NO, Mitchell HM, Leong RWL. Spp24 is associated with endocytic signalling, lipid metabolism, and discrimination of tissue integrity for 'leaky-gut' in inflammatory bowel disease. Sci Rep 2020;10:12932. [PMID: 32737354 DOI: 10.1038/s41598-020-69746-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Ambrosini YM, Neuber S, Borcherding D, Seo YJ, Segarra S, Glanemann B, Garden OA, Müller U, Adam MG, Dang V, Borts D, Atherly T, Willette AA, Jergens A, Mochel JP, Allenspach K. Treatment With Hydrolyzed Diet Supplemented With Prebiotics and Glycosaminoglycans Alters Lipid Metabolism in Canine Inflammatory Bowel Disease. Front Vet Sci 2020;7:451. [PMID: 32851029 DOI: 10.3389/fvets.2020.00451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
39 Liu F, Liu J, Wang TTY, Liu Z, Xue C, Mao X, Tang Q, Li RW. Molecular and Microbial Signatures Predictive of Prebiotic Action of Neoagarotetraose in a Dextran Sulfate Sodium-Induced Murine Colitis Model. Microorganisms 2020;8:E995. [PMID: 32635315 DOI: 10.3390/microorganisms8070995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Bos S, Laukens D. Metabolic modulation during intestinal fibrosis. J Dig Dis 2020;21:319-25. [PMID: 32406133 DOI: 10.1111/1751-2980.12882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
41 Liu T, Gu X, Li LX, Li M, Li B, Cui X, Zuo XL. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients. BMC Microbiol. 2020;20:168. [PMID: 32552668 DOI: 10.1186/s12866-020-01841-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
42 Pang Z, Chong J, Li S, Xia J. MetaboAnalystR 3.0: Toward an Optimized Workflow for Global Metabolomics. Metabolites 2020;10:E186. [PMID: 32392884 DOI: 10.3390/metabo10050186] [Cited by in Crossref: 147] [Cited by in F6Publishing: 175] [Article Influence: 73.5] [Reference Citation Analysis]
43 Tefas C, Ciobanu L, Tanțău M, Moraru C, Socaciu C. The potential of metabolic and lipid profiling in inflammatory bowel diseases: A pilot study. Bosn J Basic Med Sci 2020;20:262-70. [PMID: 31368421 DOI: 10.17305/bjbms.2019.4235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
44 Chen P, Zhou G, Lin J, Li L, Zeng Z, Chen M, Zhang S. Serum Biomarkers for Inflammatory Bowel Disease. Front Med (Lausanne). 2020;7:123. [PMID: 32391365 DOI: 10.3389/fmed.2020.00123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
45 Daniluk U, Daniluk J, Kucharski R, Kowalczyk T, Pietrowska K, Samczuk P, Filimoniuk A, Kretowski A, Lebensztejn D, Ciborowski M. Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn's Disease and Ulcerative Colitis-A Preliminary Study. Inflamm Bowel Dis 2019;25:1120-8. [PMID: 30772902 DOI: 10.1093/ibd/izy402] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 20.0] [Reference Citation Analysis]
46 Schirmer M, Garner A, Vlamakis H, Xavier RJ. Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol. 2019;17:497-511. [PMID: 31249397 DOI: 10.1038/s41579-019-0213-6] [Cited by in Crossref: 129] [Cited by in F6Publishing: 200] [Article Influence: 64.5] [Reference Citation Analysis]
47 Kim SH, Lee W, Kwon D, Lee S, Son SW, Seo MS, Kim KS, Lee YH, Kim S, Jung YS. Metabolomic Analysis of the Liver of a Dextran Sodium Sulfate-Induced Acute Colitis Mouse Model: Implications of the Gut-Liver Connection. Cells 2020;9:E341. [PMID: 32024178 DOI: 10.3390/cells9020341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
48 Baxter BA, Parker KD, Nosler MJ, Rao S, Craig R, Seiler C, Ryan EP. Metabolite profile comparisons between ascending and descending colon tissue in healthy adults. World J Gastroenterol 2020; 26(3): 335-352 [PMID: 31988593 DOI: 10.3748/wjg.v26.i3.335] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
49 Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. J Transl Med 2019;17:419. [PMID: 31836022 DOI: 10.1186/s12967-019-02174-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
50 Guan S, Jia B, Chao K, Zhu X, Tang J, Li M, Wu L, Xing L, Liu K, Zhang L, Wang X, Gao X, Huang M. UPLC–QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis. J Proteome Res 2020;19:600-9. [DOI: 10.1021/acs.jproteome.9b00440] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
51 Diab J, Hansen T, Goll R, Stenlund H, Jensen E, Moritz T, Florholmen J, Forsdahl G. Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis. Metabolites 2019;9:E291. [PMID: 31783598 DOI: 10.3390/metabo9120291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
52 Bajaj JS, Sharma A, Dudeja PK; Collaborators. Targeting Gut Microbiome Interactions in Service-Related Gastrointestinal and Liver Diseases of Veterans. Gastroenterology 2019;157:1180-1183.e1. [PMID: 31404532 DOI: 10.1053/j.gastro.2019.07.060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
53 Lin S, Wang T, Xu H, Zhang X, Wang Q, Liu R, Li Q, Bi K. A systemic combined nontargeted and targeted LC-MS based metabolomic strategy of plasma and liver on pathology exploration of alpha-naphthylisothiocyanate induced cholestatic liver injury in mice. Journal of Pharmaceutical and Biomedical Analysis 2019;171:180-92. [DOI: 10.1016/j.jpba.2019.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
54 Schiffman C, Petrick L, Perttula K, Yano Y, Carlsson H, Whitehead T, Metayer C, Hayes J, Rappaport S, Dudoit S. Filtering procedures for untargeted LC-MS metabolomics data. BMC Bioinformatics 2019;20:334. [PMID: 31200644 DOI: 10.1186/s12859-019-2871-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
55 Dovrolis N, Filidou E, Kolios G. Systems biology in inflammatory bowel diseases: on the way to precision medicine. Ann Gastroenterol 2019;32:233-46. [PMID: 31040620 DOI: 10.20524/aog.2019.0373] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
56 Scoville EA, Allaman MM, Adams DW, Motley AK, Peyton SC, Ferguson SL, Horst SN, Williams CS, Beaulieu DB, Schwartz DA, Wilson KT, Coburn LA. Serum Polyunsaturated Fatty Acids Correlate with Serum Cytokines and Clinical Disease Activity in Crohn's Disease. Sci Rep 2019;9:2882. [PMID: 30814550 DOI: 10.1038/s41598-019-39232-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
57 Lai Y, Xue J, Liu CW, Gao B, Chi L, Tu P, Lu K, Ru H. Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn's Disease. Molecules 2019;24:E449. [PMID: 30691236 DOI: 10.3390/molecules24030449] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 6.7] [Reference Citation Analysis]
58 Sugihara K, Morhardt TL, Kamada N. The Role of Dietary Nutrients in Inflammatory Bowel Disease. Front Immunol 2018;9:3183. [PMID: 30697218 DOI: 10.3389/fimmu.2018.03183] [Cited by in Crossref: 53] [Cited by in F6Publishing: 72] [Article Influence: 17.7] [Reference Citation Analysis]
59 Murgia A, Hinz C, Liggi S, Denes J, Hall Z, West J, Santoru ML, Piras C, Manis C, Usai P, Atzori L, Griffin JL, Caboni P. Italian cohort of patients affected by inflammatory bowel disease is characterised by variation in glycerophospholipid, free fatty acids and amino acid levels. Metabolomics 2018;14. [DOI: 10.1007/s11306-018-1439-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]